The global diabetic retinopathy drug market is anticipated to bolster

Posted by Satr Martin on May 23rd, 2018

Diabetic retinopathy is a medical condition which damages retina (present at the back of eye) and leads to blindness if untreated or undiagnosed. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the disease at its initial stage.

The global diabetic retinopathy drug market is anticipated to bolster at a robust growth rate to reach USD 705 Million by 2021. Geographically, the global diabetic retinopathy drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of World.

Market Segmentation

By Type of Drugs

The global diabetic retinopathy drugs market is segmented based on type of drugs into intraocular steroid injection, Avastin, Lucentis and Anti-Vascular Endothelial Growth Factor (VEGF) drug.

By End Users

On the basis of end-users, the global diabetic retinopathy drug market is divided as ophthalmic clinics, hospitals, ambulatory surgical centers and others.

Growth Drivers and challenges

Rapidly expanding diabetic population coupled with increasing awareness of people regarding diabetic retinopathy is expected to drive the growth of global diabetic retinopathy drug market in coming 4-5 years.

Request For Sample Pages:

In addition to that, rising medical procedures due to high penetration of medical insurance and rising government initiatives for prevention of diabetes related risks is also believed to garner the growth of global retinopathy drug market in future.

However, lack of trained ophthalmologist and stringent government regulations for approval of diabetic retinopathy drugs is anticipated to restrain the growth of global diabetic retinopathy drugs market over the forecast period i.e. 2015-2021.       

Market Size and Forecast

Regionally, North America dominates the global diabetic retinopathy drug market. The region also accounted for 36.0% of total diabetic retinopathy market in 2015. Diabetic retinopathy drug market in the region is expected to escalate and get sparked by huge government spending on healthcare industry in coming 5-6 years.

Europe is the second largest diabetic retinopathy drug market behind North America. The market in the region is anticipated to propagate by increasing number of obese people, who are more prone to diabetes, in some of the major European countries including the U.K., Germany, Spain, France, Italy and Spain.    

Asia-Pacific diabetic retinopathy drug market is believed to have the highest growth over the covered forecast period. Rapid expansion of diabetic population, increasing per capita income and major investments in health infrastructure are some of the key factors which are expected to propel the diabetic retinopathy drug market in countries such as India and China over next 4-5 years.

Request For TOC Here: -

Japan diabetic retinopathy drug market is also anticipated to witness a burgeoned expansion fuelled by rapid growth of geriatric population in the country.

Key Players

Global diabetic retinopathy market is very competitive and includes some of the top players such as Roche, Moore Drug Company, Regeneron Pharmaceuticals Inc., Bayer Healthcare, ThromboGenics, Actavis PLC, Actavis PLC, Sirnaomics Incorporation, Parexel International Corp., etc.

Scope and Context

Overview of the Parent Market

Analyst View

Market Size and Growth

North America (U.S., Canada)

Latin America (Mexico, Brazil, Rest of Latin America)

Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)

Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)

Rest of World


By Type of Drugs

By End Users

By Geography

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Read More Information:

For Table of Content & Free Sample Report Contact:

Name:-Ajay Daniel


U.S. +1 646 586 9123

U.K. +44 203 608 5919

Like it? Share it!

Satr Martin

About the Author

Satr Martin
Joined: December 4th, 2017
Articles Posted: 159

More by this author